Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

TLDR

Abstract

Journal Article Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Get access Anne Monks, Anne Monks * Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. * Correspondence to: Anne Monks, PhD, NCl-Frederick Cancer Research and Development Center, Bldg 432, Rm 232, Frederick, MD 21701-1013 Search for other works by this author on: Oxford Academic PubMed Google Scholar Dominic Scudiero, Dominic Scudiero Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Philip Skehan, Philip Skehan Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Robert Shoemaker, Robert Shoemaker Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Kenneth Paull, Kenneth Paull Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar David Vistica, David Vistica Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Curtis Hose, Curtis Hose Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar John Langley, John Langley Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Paul Cronise, Paul Cronise Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Anne Vaigro-Wolff, Anne Vaigro-Wolff Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more Marcia Gray-Goodrich, Marcia Gray-Goodrich Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Hugh Campbell, Hugh Campbell Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Joseph Mayo, Joseph Mayo Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Michael Boyd Michael Boyd Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 83, Issue 11, 5 June 1991, Pages 757–766, https://doi.org/10.1093/jnci/83.11.757 Published: 05 June 1991 Article history Received: 19 November 1990 Revision received: 08 March 1991 Accepted: 20 March 1991 Published: 05 June 1991